TONGLI PHARMACEUTICALS (USA), INC. Earnings Per Share, Basic and Diluted
TONGLI PHARMACEUTICALS (USA), INC. reported Earnings Per Share, Basic and Diluted of -$0.01 per share for the 3-month period ending 2013-12-31, per its 10-Q filed 2014-02-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2014-02-14
- TONGLI PHARMACEUTICALS (USA), INC. earnings per share, basic and diluted for the quarter ending 2013-12-31 was -$0.01, a 111.11% decline year-over-year.
- TONGLI PHARMACEUTICALS (USA), INC. earnings per share, basic and diluted for the quarter ending 2013-09-30 was -$0.01, a 116.67% decline year-over-year.
- TONGLI PHARMACEUTICALS (USA), INC. earnings per share, basic and diluted for the quarter ending 2013-06-30 was $0.01.
- TONGLI PHARMACEUTICALS (USA), INC. earnings per share, basic and diluted for the quarter ending 2013-03-31 was -$0.01.
- TONGLI PHARMACEUTICALS (USA), INC. earnings per share, basic and diluted for fiscal 2013 was $0.11, a 35.29% decline from fiscal 2012.
- TONGLI PHARMACEUTICALS (USA), INC. earnings per share, basic and diluted for fiscal 2012 was $0.17, a 54.05% decline from fiscal 2011.
- TONGLI PHARMACEUTICALS (USA), INC. earnings per share, basic and diluted for fiscal 2011 was $0.37.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2013-12-31 | -$0.01 10-Q · filed 2014-02-14 | -$0.03 derived: net income ÷ weighted average shares · filed 2014-02-14 | -$0.02 10-Q · filed 2014-02-14 | -$0.03 derived: net income ÷ weighted average shares · filed 2014-02-14 |
| 2013-09-30 | -$0.01 10-Q · filed 2013-11-14 | -$0.01 10-Q · filed 2013-11-14 | -$0.02 derived: net income ÷ weighted average shares · filed 2013-11-14 | $0.07 derived: net income ÷ weighted average shares · filed 2014-02-14 |
| 2013-06-30 | $0.01 10-Q · filed 2013-08-19 | -$0.00 derived: net income ÷ weighted average shares · filed 2013-08-19 | $0.09 derived: net income ÷ weighted average shares · filed 2014-02-14 | $0.14 derived: net income ÷ weighted average shares · filed 2014-02-14 |
| 2013-03-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2013-06-28 | $0.08 derived: net income ÷ weighted average shares · filed 2014-02-14 | $0.14 derived: net income ÷ weighted average shares · filed 2014-02-14 | $0.11 10-K · filed 2013-06-28 |
| 2012-12-31 | $0.09 10-Q · filed 2014-02-14 | $0.15 derived: net income ÷ weighted average shares · filed 2014-02-14 | $0.12 10-Q · filed 2014-02-14 | $0.04 derived: net income ÷ weighted average shares · filed 2014-02-14 |
| 2012-09-30 | $0.06 10-Q · filed 2013-11-14 | $0.02 10-Q · filed 2013-11-14 | -$0.05 derived: net income ÷ weighted average shares · filed 2013-11-14 | $0.04 derived: net income ÷ weighted average shares · filed 2013-11-14 |
| 2012-06-30 | -$0.04 10-Q · filed 2013-08-19 | -$0.12 derived: net income ÷ weighted average shares · filed 2013-08-19 | -$0.02 derived: net income ÷ weighted average shares · filed 2013-08-19 | $0.01 derived: net income ÷ weighted average shares · filed 2013-08-19 |
| 2012-03-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2013-06-28 | $0.02 derived: net income ÷ weighted average shares · filed 2013-06-28 | $0.04 derived: net income ÷ weighted average shares · filed 2013-06-28 | $0.17 10-K · filed 2013-06-28 |
| 2011-12-31 | $0.10 10-Q · filed 2013-02-14 | $0.13 derived: net income ÷ weighted average shares · filed 2013-02-14 | $0.26 10-Q · filed 2013-02-14 | |
| 2011-09-30 | $0.03 10-Q · filed 2012-11-14 | $0.16 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | $0.14 10-Q/A · filed 2012-09-06 | |||
| 2011-03-31 | $0.37 10-K · filed 2012-07-16 | |||
| 2010-12-31 | $0.12 10-Q · filed 2012-02-14 | $0.24 10-Q · filed 2012-02-14 | ||
| 2010-09-30 | $0.03 10-Q · filed 2011-11-15 | $0.11 10-Q · filed 2011-11-15 | ||
| 2010-06-30 | $0.08 10-Q/A · filed 2011-09-02 |